Kim Tzoumakas

Kim Tzoumakas serves as Chief Executive Officer at Maxor National Pharmacy Services, LLC. Maxor National Pharmacy Services, LLC operates in the hospital & health care sector with approximately 790.0 employees. The company is headquartered in Birmingham, Michigan. Maxor National Pharmacy Services, LLC generates annual revenue of 310000000.0.

Industry & Role Insights

• • MessageCEO tracks 6,447 executives in the hospital & health care sector.
• • We have verified contacts for 3 executives at Maxor National Pharmacy Services, LLC.
• • 1,434 executive contacts are available in Michigan.
• • Our database includes 201,469 c suite-level executives.

Cloudflare DNS Outlook Pardot MailChimp SPF Google Cloud Hosting Microsoft Office 365 CloudFlare Hosting Atlassian Confluence React Salesforce Hubspot Typekit reCAPTCHA YouTube Gravity Forms Adobe Media Optimizer Google Tag Manager Vimeo WordPress.org Mobile Friendly Cedexis Radar Remote AI Node.js Android Data Analytics Circle

healthcare pharmacy pharmacy benefit management correctional pharmacy pharmacy management pharmacy consulting third party administrative services 340b pharmacy operations pharmacy technology mail order pharmacy specialty pharmacy home infusion pharmacy hospitals & health care pharmacy services 340b program patient engagement prescription delivery clinical management healthcare providers pharmacy solutions cost management medication adherence custom pharmacy plans prescription assistance operational control enhanced reporting healthcare compliance formulary management drug utilization review financial performance patient satisfaction healthcare innovation healthcare outcomes patient-centric care chronic disease management medication therapy management collaborative care drug discount programs clinical protocols care coordination onsite pharmacy services limited distribution drugs healthcare partnerships patient education specialty drug management cost savings health system integration patient portal telepharmacy services quality improvement programs integrated pharmacy services networking & collaboration pharmacy staff training service integration pharmacy operations healthcare cost reduction pharmacy care solutions patient outcomes 340b program management operational oversight home delivery pharmacy pharmacies patient access cost reduction outpatient services inpatient services community health diverse patient population collaboration healthcare optimization health systems pharmacy network compliance customized pharmacy offerings superior service comprehensive pharmacy management clinical integration pharmacy ecosystem patient-centered care health care health wellness & fitness hospital & health care

ME

Mike Ellis Chief Executive Officer at Maxor National Pharmacy Services, LLC

LC

Lorrie Carr Chief Executive Officer at Maxor National Pharmacy Services, LLC

DR

Donna Rey Executive Director & CEO at 1199SEIU National Benefit Fund

AS

Amin Shivji Chief Executive Officer at 123Dentist

JL

Jeff Leger Chief Executive Officer (incoming) at 123Dentist

How can I contact Kim Tzoumakas?

Kim Tzoumakas's verified email address is available on MessageCEO. They currently work at Maxor National Pharmacy Services, LLC. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Kim Tzoumakas lead?

Kim Tzoumakas is Chief Executive Officer at Maxor National Pharmacy Services, LLC, a company in the hospital & health care sector with 790.0 employees. The company is based in Birmingham, Michigan.

What industry is Kim Tzoumakas in?

Kim Tzoumakas works in the hospital & health care industry as Chief Executive Officer at Maxor National Pharmacy Services, LLC. MessageCEO provides verified contact information for executives across all major industries.

Is Kim Tzoumakas's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Kim Tzoumakas's profile is kept up-to-date with the latest available information.

Last updated: April 17, 2026